BRPI0619120B1 - Processo para a fabricação de derivados de epóxi triazol - Google Patents

Processo para a fabricação de derivados de epóxi triazol Download PDF

Info

Publication number
BRPI0619120B1
BRPI0619120B1 BRPI0619120-7A BRPI0619120A BRPI0619120B1 BR PI0619120 B1 BRPI0619120 B1 BR PI0619120B1 BR PI0619120 A BRPI0619120 A BR PI0619120A BR PI0619120 B1 BRPI0619120 B1 BR PI0619120B1
Authority
BR
Brazil
Prior art keywords
formula
compound
hal
reaction
prg
Prior art date
Application number
BRPI0619120-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Marc Muller
Lin Xu
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of BRPI0619120A2 publication Critical patent/BRPI0619120A2/pt
Publication of BRPI0619120B1 publication Critical patent/BRPI0619120B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
BRPI0619120-7A 2005-12-01 2006-11-29 Processo para a fabricação de derivados de epóxi triazol BRPI0619120B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05026163.5 2005-12-01
EP05026163 2005-12-01
PCT/CH2006/000671 WO2007062542A2 (en) 2005-12-01 2006-11-29 Process for the manufacture of epoxybutanol intermediates

Publications (2)

Publication Number Publication Date
BRPI0619120A2 BRPI0619120A2 (pt) 2011-09-13
BRPI0619120B1 true BRPI0619120B1 (pt) 2023-10-10

Family

ID=36178579

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619120-7A BRPI0619120B1 (pt) 2005-12-01 2006-11-29 Processo para a fabricação de derivados de epóxi triazol

Country Status (19)

Country Link
US (2) US7816537B2 (enExample)
EP (2) EP1954264B1 (enExample)
JP (1) JP5329969B2 (enExample)
KR (1) KR101191682B1 (enExample)
CN (1) CN101321522B (enExample)
AT (1) ATE444747T1 (enExample)
AU (2) AU2006319657B2 (enExample)
BR (1) BRPI0619120B1 (enExample)
CA (2) CA2711852C (enExample)
CY (1) CY1110588T1 (enExample)
DE (1) DE602006009698D1 (enExample)
DK (1) DK1954264T3 (enExample)
ES (1) ES2333258T3 (enExample)
HR (1) HRP20090675T1 (enExample)
PL (1) PL1954264T3 (enExample)
PT (1) PT1954264E (enExample)
SI (1) SI1954264T1 (enExample)
WO (1) WO2007062542A2 (enExample)
ZA (1) ZA200804218B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5767643B2 (ja) 2009-09-21 2015-08-19 ギリード・サイエンシズ・インコーポレーテッド 1’−置換カルバヌクレオシド類似体の調製のためのプロセスおよび中間体
PE20130400A1 (es) 2010-07-22 2013-04-10 Gilead Sciences Inc Metodos y compuestos para tratar infecciones virales por paramyxoviridae
JP6334529B2 (ja) 2012-08-07 2018-05-30 バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG イサブコナゾールまたはラブコナゾールの製造方法
WO2015150947A1 (en) 2014-03-29 2015-10-08 Wockhardt Limited A process for the preparation of isavuconazole and its intermediates
TWI698444B (zh) 2014-10-29 2020-07-11 美商基利科學股份有限公司 製備核糖苷的方法
PT3349758T (pt) 2015-09-16 2022-07-13 Gilead Sciences Inc Métodos para o tratamento de infeções pelo vírus arenaviridae
CN105367528A (zh) * 2015-11-10 2016-03-02 南通诺泰生物医药技术有限公司 一种三唑类药物中间体(d)-1-(1-环烷仲胺基)-2-(2-四氢吡喃基)氧-1-丙酮类化合物及合成方法
CN110869028B (zh) 2017-03-14 2023-01-20 吉利德科学公司 治疗猫冠状病毒感染的方法
KR20190141747A (ko) 2017-05-01 2019-12-24 길리애드 사이언시즈, 인코포레이티드 (S)-2-에틸부틸 2-(((S)-(((2R,3S,4R,5R)-5-(4-아미노피롤로[2,1-f] [1,2,4]트리아진-7-일)-5-시아노-3,4-디히드록시테트라히드로푸란-2-일)메톡시)(페녹시) 포스포릴)아미노)프로파노에이트의 결정질 형태
US10675296B2 (en) 2017-07-11 2020-06-09 Gilead Sciences, Inc. Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
SG11201911637QA (en) 2017-08-10 2020-01-30 Sumitomo Chemical Co Process for producing epoxy alcohol compound
CN118766947A (zh) 2020-01-27 2024-10-15 吉利德科学公司 用于治疗SARS CoV-2感染的方法
CA3169340A1 (en) 2020-03-12 2021-09-16 Pavel R. Badalov Methods of preparing 1'-cyano nucleosides
JP7482250B2 (ja) 2020-04-06 2024-05-13 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノ置換カルバヌクレオシド類似体の吸入製剤
PL4157272T3 (pl) 2020-05-29 2025-10-20 Gilead Sciences, Inc. Remdesiwir do leczenia zakażeń wirusowych
JP2023531524A (ja) 2020-06-24 2023-07-24 ギリアード サイエンシーズ, インコーポレイテッド 1’-シアノヌクレオシド類似体及びその使用
LT4204421T (lt) 2020-08-27 2024-06-25 Gilead Sciences, Inc. Virusinių infekcijų gydymui skirti junginiai ir būdai
US20230295172A1 (en) 2022-03-02 2023-09-21 Gilead Sciences, Inc. Compounds and methods for treatment of viral infections
CN115536643A (zh) * 2022-12-05 2022-12-30 南京桦冠生物技术有限公司 一种艾沙康唑类药物关键中间体的制备方法
US12357577B1 (en) 2024-02-02 2025-07-15 Gilead Sciences, Inc. Pharmaceutical formulations and uses thereof
CN119264078B (zh) * 2024-12-09 2025-08-01 浙江世佳科技股份有限公司 一种(5s,6r)-5,6-环氧-2-十七碳炔-1-醇的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3452213B2 (ja) * 1994-07-05 2003-09-29 エーザイ株式会社 抗真菌剤及びその製造方法
WO1999045008A1 (en) * 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
US6133485A (en) * 1998-04-15 2000-10-17 Synphar Laboratories, Inc. Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
US6391903B1 (en) * 1999-09-09 2002-05-21 Sankyo Company, Limited Triazole derivatives having antifungal activity
US6884892B2 (en) * 2002-06-20 2005-04-26 Sumitomo Chemical Company, Limited Production methods of epoxytriazole derivative and intermediate therefor
JP4627413B2 (ja) * 2003-05-06 2011-02-09 三井化学株式会社 1−アゾール−2−フェニル−2、3−プロパンジオール誘導体の製造法

Also Published As

Publication number Publication date
PL1954264T3 (pl) 2010-02-26
CA2711852A1 (en) 2007-06-07
WO2007062542A3 (en) 2007-11-01
WO2007062542A2 (en) 2007-06-07
CA2629092A1 (en) 2007-06-07
ATE444747T1 (de) 2009-10-15
HRP20090675T1 (hr) 2010-01-31
US20110021794A1 (en) 2011-01-27
JP5329969B2 (ja) 2013-10-30
US7816537B2 (en) 2010-10-19
DE602006009698D1 (de) 2009-11-19
CN101321522B (zh) 2012-05-30
PT1954264E (pt) 2009-12-23
KR20080075014A (ko) 2008-08-13
CA2711852C (en) 2011-10-04
EP2133345A1 (en) 2009-12-16
AU2010203301B2 (en) 2012-06-21
EP1954264A2 (en) 2008-08-13
ES2333258T3 (es) 2010-02-18
AU2006319657B2 (en) 2010-08-12
KR101191682B1 (ko) 2012-10-16
BRPI0619120A2 (pt) 2011-09-13
AU2006319657A1 (en) 2007-06-07
CN101321522A (zh) 2008-12-10
AU2010203301A1 (en) 2010-08-12
EP1954264B1 (en) 2009-10-07
SI1954264T1 (sl) 2010-01-29
CY1110588T1 (el) 2015-04-29
ZA200804218B (en) 2009-01-28
US8076494B2 (en) 2011-12-13
JP2009517413A (ja) 2009-04-30
DK1954264T3 (da) 2010-01-11
US20090299073A1 (en) 2009-12-03
CA2629092C (en) 2012-01-03

Similar Documents

Publication Publication Date Title
US8076494B2 (en) Process for the manufacture of epoxy triazole derivatives
JP2009517413A5 (enExample)
ES2218173T3 (es) Acidos 2-alquil-5-halogano-pent-4-enocarboxilicos y su fabricacion.
FI78293B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara aminocyklopentanalkenkarboxylsyror och deras estrar.
US4389413A (en) 9,11-Methano-13-aza-11a-carbathrombanoic acid analogues
US6133485A (en) Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols
JP2002511434A5 (enExample)
JPH0641114A (ja) 新規メバロノラクトン類とその製法
NO861867L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heksensyrer.
JP3084578B2 (ja) 光学活性化合物の製造法
WO1999014210A1 (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
HU189674B (en) Improved process for preparing hydroxyethyl-tetrazole-thiol
DE69126593T2 (de) Heterozyklische Säuren
IE903146A1 (en) Asymmetric chemical synthesis and intermediates for making¹antifungal compounds
HU207711B (en) Process for producing glutaric acid derivatives
JPH0249311B2 (enExample)
US4169199A (en) Precursors for prostaglandin analogue and process for preparing the same
JPH0272166A (ja) 光学活性オキシラン類
JP2018172309A (ja) 光学活性な環状アミン誘導体又はその塩の製造方法
HU208435B (en) New process for producing substituted cyclopentenone- and cyclohexanone derivatives
HU184513B (en) Process for preparing prostaglandin-f down 2 alpha-derivatives
HU180705B (hu) Eljárás új 4-ariltiometil-2H-ciklopentano[b]furán-származékok előállítására
JP2004269381A (ja) フィトスフィンゴシン類縁体およびその製法
HU180635B (en) Process for producing 3-substituted-2-cyclopentanoe derivatives
JPH1087645A (ja) β−アミノエステルの製造法

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/11/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.